高级搜索

人mcl1不同亚型在结肠癌组织中表达变化的临床意义

崔凯, 王焕, 冯衍生

崔凯, 王焕, 冯衍生. 人mcl1不同亚型在结肠癌组织中表达变化的临床意义[J]. 肿瘤防治研究, 2016, 43(2): 141-145. DOI: 10.3971/j.issn.1000-8578.2016.02.010
引用本文: 崔凯, 王焕, 冯衍生. 人mcl1不同亚型在结肠癌组织中表达变化的临床意义[J]. 肿瘤防治研究, 2016, 43(2): 141-145. DOI: 10.3971/j.issn.1000-8578.2016.02.010
CUI Kai, WANG Huan, FENG Yansheng. Clinical Significance of Different Human mcl1 Subtypes Expression in Colorectal Cancer Tissues[J]. Cancer Research on Prevention and Treatment, 2016, 43(2): 141-145. DOI: 10.3971/j.issn.1000-8578.2016.02.010
Citation: CUI Kai, WANG Huan, FENG Yansheng. Clinical Significance of Different Human mcl1 Subtypes Expression in Colorectal Cancer Tissues[J]. Cancer Research on Prevention and Treatment, 2016, 43(2): 141-145. DOI: 10.3971/j.issn.1000-8578.2016.02.010

人mcl1不同亚型在结肠癌组织中表达变化的临床意义

基金项目: 国家自然科学基金青年科学基金项目(81300113)
详细信息
    作者简介:

    崔凯(1981-),男,硕士,主治医师,主要从事结肠癌基因方面研究

  • 中图分类号: R735.3+5

Clinical Significance of Different Human mcl1 Subtypes Expression in Colorectal Cancer Tissues

  • 摘要: 目的 探讨人mcl1基因不同亚型在结肠癌组织中差异表达的临床意义。方法 采用RT-PCR和Western blot分别检测正常结肠组织、结肠腺瘤、结肠腺癌组织以及相应的癌旁组织各20例中mcl1基因三种mRNA剪接异构体和三种蛋白亚型的表达水平,进而分析这些亚型表达差异与肿瘤临床病理特征之间的相关性。结果 mcl1基因亚型1在结肠肿瘤组织及相应旁组织中的mRNA和蛋白质水平表达均高于正常组(P=0.009, P=0.022),且腺癌组中的mRNA和蛋白质水平表达亦高于腺瘤组(P=0.004, P=0.034)。亚型2在结肠肿瘤组织及对应旁组织中的mRNA和蛋白质水平表达均高于正常组(P=0.002, P=0.011),且腺癌组中的mRNA和蛋白质水平表达亦高于腺瘤组(P<0.001, P=0.007)。亚型3在结肠肿瘤组织及对应旁组织中的mRNA和蛋白质水平表达均高于正常组(P=0.027, P=0.045),但肿瘤组与相应旁组织之间以及腺癌组与腺瘤组之间的比较差异均无统计学意义。结论 研究表明mcl1亚型1和亚型2对结肠癌肿瘤恶性程度呈正相关,可以作为临床评估结肠癌恶性程度有效的诊断指标之一。而亚型3可以作为肿瘤早期诊断的标志物,但其表达水平与恶性程度无明显相关性。

     

    Abstract: Objective To investigate the clinical significance of differential human mcl1 subtypes expression in colorectal cancer tissues. Methods The differential expression of three mRNA splicing variants and protein subtypes of mcl1 were detected in each 20 cases of normal colon tissues, colorectal adenoma, colorectal adenocarcinoma and their relative para-carcinoma tissues using RT-PCR and Western blot, and then we further analyzed the relationship of these variants expression with clinicopathological characteristics in the colon tumors. Results The expression of subtypes 1 and 2 of mcl1 were higher in colon tumor tissues and relative para-carcinoma tissues than those in normal control, and higher in the adenocarcinoma tissues than those in adenoma tissues . The expression of subtype 3 of mcl1 were higher in colon tumor tissues and relative para-carcinoma tissues than those in normal control, but no statistical significance in the comparison between tumor tissues and their relative para-carcinoma tissues as well as the comparison between adenocarcinoma tissues and adenoma tissues. Conclusion The subtypes 1 and 2 of mcl1 expression are demonstrated as a positive correlation with the malignancy level of colon tumor and could be used as efficient biomarkers in clinical diagnosis. The subtypes 3 could be used as an early biomarker for colon tumor diagnosis, while its expression has no significant correlation with the malignancy level of colon tumor.

     

  • [1] Tárraga López PJ, Albero JS, Rodríguez-Montes JA. Primary and secondary prevention of colorectal cancer[J]. Clin Med Insights Gastroenterol, 2014, 7: 33-46.
    [2] Zhao Y, Shen XY. The anti apoptotic function of Mcl-1 and its role in cancer treatment[J]. Sheng Ming De Hua Xue, 2011, 31(6): 86 3-7. [赵燕, 沈晓云. Mcl-1蛋白的抗凋亡作用与癌症的治疗 [J] 生命的化学, 2011, 31(6): 863-7.]
    [3] Bingle CD, Craig RW, Swales BM, et al. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death[J]. J Biol Chem, 2000, 275(29): 22136-46.
    [4] Jamil S, Sobouti R, Hojabrpour P, et al. A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1[J]. Biochem J, 2005, 398(Pt 3): 659-67.
    [5] Kitada S, Andersen J, Akar S, et al. Expression of apoptosisregulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses[J]. Blood, 1998, 91(9): 33 79-89.
    [6] Taniai M, Grambihler A, Higuchi H, et al. MCL-1 mediates tumor necrosis factor-related aptoptosis-indcing ligand resistance in human cholangicarcinoma cells[J]. Cancer Res, 2004, 64(10): 35 17-24.
    [7] Zhang Y. The expression andclinicopathological significance of eIF3a, mcl-1 and CD83 in colorectal carcinoma tissue and serum[D]. Suzhou Da Xue, 2014, 36-37. [张叶. eIF3a, mcl-1和 CD83在结肠癌组织和血清中的表达及其临床病理意义[D].苏 州大学, 2014, 36-37.]
    [8] Germain M, Duronio V. The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function [J] J Biol Chem, 2007, 282(44): 32233-42.
    [9] Song L, Coppola D, Livingaton S, et al. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells[J]. Cancer Biol Ther, 2005, 4(3): 267-76.
    [10] Schulze-Bergkamen H, Flerscher B, Schuchmann M, et al. Suppression of mcl-1via RNA interference sensitizes human heaptocellular carcinoma cells towards apoptosis induction[J]. BMC Cancer, 2006, 6: 232.
    [11] Yoon JH, Werneburg NW, Higuchi H, et al. Bile acids inhibit Mcl- 1p rotein turnover via an epidermal growth factor receptor/Raf-1 dependent mechanism[J]. Cancer Res, 2002, 62(22): 6500-5.
    [12] Hernandez JM, Farma JM, Coppola D, et al. Expression of the antiapoptotic protein survivin in colon cancer[J]. Clin Colorectal Cancer, 2011, 10(3): 188-93.
    [13] Eichhorn JM, Alford SE, Sakurikar N, et al. Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival[J]. Exp Cell Res, 2014, 322(2): 41 5-24.
    [14] Feng N, Zhang XJ. Progress of Mcl-1 gene in targeted therapy of tumor[J]. Zhonghua Lin Chuang Yi Shi Za Zhi(Dian Zi Ban), 20 09, 3(11): 1883-7. [冯楠, 张学军. Mcl-1基因在肿瘤靶向治 疗中的研究进展[J]. 中华临床医师杂志(电子版), 2009, 3(11): 18 83-7.]
    [15] Ma XT, Yu LW, Wang S, et al. The role of bcl-2 in the inhibition of cell apoptosis of colon cancer through Stat5b signaling pathway [J] Zhonghua Shi Yan Wai Ke Za Zhi, 2005, 22(10): 1167-9. [马 向涛, 余力伟, 王杉,等. Stat5b信号通路调控bcl-2成员表达抑制 结肠癌细胞凋亡的作用及其机制[J]. 中华实验外科杂志, 2005, 22 (10): 1167-9.]
计量
  • 文章访问数:  1050
  • HTML全文浏览量:  336
  • PDF下载量:  365
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-12-30
  • 修回日期:  2015-07-31
  • 刊出日期:  2016-02-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭